Effects of Fenofibrate on Endothelial Progenitor Cell Levels in Type 1 Diabetic Patients With Retinopathy. A Randomized Controlled Trial.
Latest Information Update: 13 Aug 2021
At a glance
- Drugs Fenofibrate (Primary)
- Indications Diabetic retinopathy
- Focus Pharmacodynamics
- 09 Aug 2021 Primary endpoint (Circulating progenitor cells) has been met, as per results published in the Diabetologia.
- 09 Aug 2021 Primary endpoint (Endothelial progenitor cells) has been met, as per results published in the Diabetologia.
- 09 Aug 2021 Results assessing the effect of fenofibrate on HSPC levels in participants with retinopathy and also re-analysed historical data to examine to what extent the observed effect of fenofibrate on HSPCs, published in the Diabetologia